Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.70 |
| ▸ | POLB | P06746 | 2/20 | 0.67 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1962312 | 0.86 | HSD17B10 (0.77) | HSD17B10SMN1; SMN2POLBALOX12ALOX15 | |
| SCHEMBL30122631 | 0.85 | MAPK1 (0.75) | HSD17B10SMN1; SMN2POLBALOX12ALOX15 | |
| SCHEMBL1682746 | 0.85 | MAPK1 (0.75) | HSD17B10SMN1; SMN2POLBALOX12ALOX15 | |
| SCHEMBL29154650 | 0.84 | HSD17B10 (0.75) | HSD17B10SMN1; SMN2POLBALOX12ALOX15 | |
| SCHEMBL29154635 | 0.84 | HSD17B10 (0.75) | HSD17B10SMN1; SMN2POLBALOX12ALOX15 | |
| SCHEMBL30726096 | 0.84 | HSD17B10 (0.75) | HSD17B10SMN1; SMN2POLBALOX12ALOX15 | |
| SCHEMBL30726098 | 0.84 | HSD17B10 (0.75) | HSD17B10SMN1; SMN2POLBALOX12ALOX15 | |
| SCHEMBL30726097 | 0.84 | HSD17B10 (0.75) | HSD17B10SMN1; SMN2POLBALOX12ALOX15 | |
| SCHEMBL4958753 | 0.84 | MAPK1 (0.70) | HSD17B10SMN1; SMN2POLBALOX12MAPK1 | |
| SCHEMBL29839760 | 0.83 | HSD17B10 (0.73) | HSD17B10SMN1; SMN2POLBALOX12ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008094909-A2 | QUINAZOLINONE AND FUSED PYRIMIDINONE COMPOUNDS AND THEIR USE IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS | XENON PHARMACEUTICALS INC. (CA) | 2008-08-07 | — | — | WO | claimed |
| WO-2008094909-A2 | QUINAZOLINONE AND FUSED PYRIMIDINONE COMPOUNDS AND THEIR USE IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS | XENON PHARMACEUTICALS INC. (CA) | 2008-08-07 | — | — | WO | disclosed |
| WO-2008094909-A2 | QUINAZOLINONE AND FUSED PYRIMIDINONE COMPOUNDS AND THEIR USE IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS | XENON PHARMACEUTICALS INC. (CA) | 2008-08-07 | — | — | WO | disclosed |